본문 바로가기
KERD
논문KCI 등재

자살 위험성 및 자살 시도 방지에 대한 전기경련치료의 역할

The Electroconvulsive Therapy in the Prevention of Suicide Risks and Attempts

정성훈|김용식|김희철|박승현|안용민|정인원
대한생물정신의학회 (The Korean Society Of Biological Psychiatry)|2020.10|생물정신의학 (Journal of Korean Society of Biological Psychiatry)|제27권 제2호|pp. 64-73|DOI 10.22857/kjbp.2020.27.2.004

1

조회

0

다운로드

1

인용

0

참고문헌

주제분류정신과학

초록

Suicidality is the most serious complication of mood disorders and psychosis; effective treatment should reduce suicide rates. The Organization for Economic Cooperation and Development age-standardized suicide rate in Korea was 22.6 in 2018, much higher compared to other countries worldwide. As mental and psychiatric problems are the main reasons for suicide attempts, accounting for 31.6% in 2018, targeting such problems should be the focus of efforts to reduce suicide rates. However, the ability of current pharmacotherapeutic and psychotherapeutic interventions to reduce suicide rates is limited due to their delayed effects. Therefore, electroconvulsive therapy (ECT) has been proposed as an alternative treatment. This approach is effective for treating most mental disorders associated with high suicide rates, including severe depression, bipolar disorder, and intractable psychotic disorders; ECT is also effective for Parkinson’s disease, which has the highest suicide rate among all disorders in Korea. The acute, long-term, and prophylactic effects of ECT on suicidality have been reported in the literature, and treatment guidelines outside of Korea recommend that ECT be used at an early stage for rapid reduction of suicide rates, as opposed to being applied as a treatment of last resort. However, only ~0.092 of every 10000 members of the Korean general population received ECT in 2018; this is much lower than the average rate worldwide, of 2.2 per 10000. Elimination of obstacles to the use of ECT, early crisis intervention involving administration of ECT for rapid stabilization, and maintenance ECT to prevent recurrence should reduce suicide rates.

Abstract

Suicidality is the most serious complication of mood disorders and psychosis; effective treatment should reduce suicide rates. The Organization for Economic Cooperation and Development age-standardized suicide rate in Korea was 22.6 in 2018, much higher compared to other countries worldwide. As mental and psychiatric problems are the main reasons for suicide attempts, accounting for 31.6% in 2018, targeting such problems should be the focus of efforts to reduce suicide rates. However, the ability of current pharmacotherapeutic and psychotherapeutic interventions to reduce suicide rates is limited due to their delayed effects. Therefore, electroconvulsive therapy (ECT) has been proposed as an alternative treatment. This approach is effective for treating most mental disorders associated with high suicide rates, including severe depression, bipolar disorder, and intractable psychotic disorders; ECT is also effective for Parkinson’s disease, which has the highest suicide rate among all disorders in Korea. The acute, long-term, and prophylactic effects of ECT on suicidality have been reported in the literature, and treatment guidelines outside of Korea recommend that ECT be used at an early stage for rapid reduction of suicide rates, as opposed to being applied as a treatment of last resort. However, only ~0.092 of every 10000 members of the Korean general population received ECT in 2018; this is much lower than the average rate worldwide, of 2.2 per 10000. Elimination of obstacles to the use of ECT, early crisis intervention involving administration of ECT for rapid stabilization, and maintenance ECT to prevent recurrence should reduce suicide rates.

참고문헌 (109)

  1. Ryan CJ, "Suicide risk assessment: where are we now?", Med J Aust, 198, pp.462~463 (2013)
  2. 2019 White Book of Suicide Prevention, "Ministry of Health and Welfare, Korea Suicide Prevention Center", Korea Suicide Prevention Center, ~ (2019)
  3. Causes of Death Statistics in 2018, "Statistics Korea", Statistics Korea, ~ (2019)
  4. 2018 Statistics Data, "Korea Suicide Prevention Center", Korea Suicide Prevention Center, ~ (2019)
  5. Analysis of demographic characteristics and follow-up service results of suicide attempters – focusing on institutes of 2017emergency room-based suicide attempter aftercare programs, "Korea Suicide Prevention Center, Emergency Room Support Team", KSPC, 1~12 (2018)
  6. Production and Development of OECD Health Care Quality Indicators in 2014, "Ministry of Health and Welfare, Health Insurance Review & Assessment Service", Ministry of Health and Welfare, ~ (2016)
  7. Reinforcing the Care Programs for the Suicide Attempters in Korea, "Lee S", Korea Institute for Health and Social Affairs, ~ (2017)
  8. Kim B, "Sex difference in risk period for completed suicide following prior attempts: Korea National Suicide Survey (KNSS)", J Affect Disord, 227, pp.861~868 (2018)
  9. Irigoyen M, "Predictors of re-attempt in a cohort of suicide attempters : a survival analysis", J Affect Disord, 247, pp.20~28 (2019)
  10. Large MM, "The role of prediction in suicide prevention", Dialogues Clin Neurosci, 20, pp.197~205 (2018)
  11. Ballard ED, "Preventing suicide : a multicausal model requires multimodal research and intervention", Bipolar Disord, 20, pp.558~559 (2018)
  12. Kellner CH, "Electroconvulsive therapy(ECT)and suicide prevention", Curr Treat Options Psychiatry, 3, pp.73~81 (2016)
  13. 김세주, "급성기 양극성우울증 약물치료 전략", 신경정신의학, 57(4), pp.287~300 (2018), 대한신경정신의학회[DOI]
  14. Young Sup Woo, "Korean Medication Algorithm Project for Bipolar Disorder 2018 (KMAP-BP 2018): Fourth Revision", Clinical Psychopharmacology and Neuroscience, 16(4), pp.434~448 (2018), 대한정신약물학회[DOI]
  15. Korean Schizophrenia Pharmacotherapy Guideline, "Working Committee for Algorithm Revision on Korean Schizophrenia Pharmacotherapy", Korean College of Neuropsychopharmacology;Korean Society of Schizophrenia Research, ~ (2019)
  16. 윤탁, "전기경련치료의 최적화를 위한 최근 동향", 신경정신의학, 55(1), pp.12~24 (2016), 대한신경정신의학회[DOI]
  17. 김원, "한국형 양극성 장애 약물치료 알고리듬 2018 : 총론", Mood and Emotion, 16(1), pp.1~12 (2018), 대한우울조울병학회
  18. 김성완, "자살예방에 대한 사회정신의학적 접근", 대한의사협회지, 62(2), pp.93~101 (2019), 대한의사협회[DOI]
  19. Man JJ, "The Medical Basis of Psychiatry", pp.687~706 (2016), Springer
  20. 나기회, "정신건강센터 등록 회원 자살사망자 특성", 대한조현병학회지, 20(2), pp.55~60 (2017), 대한조현병학회
  21. "Psychological Autopsy Analysis Result Data"[URL]
  22. Arató M, "Retrospective psychiatric assessment of 200 suicides in Budapest", Acta Psychiatr Scand, 77, pp.454~456 (1988)
  23. Cavanagh JT, "Psychological autopsy studies of suicide : a systematic review", Psychol Med, 33, pp.395~405 (2003)
  24. Lee AS, "The long-term outcome of Maudsley depressives", Br J Psychiatry, 153, pp.741~751 (1988)
  25. 김호정, "항우울제 사용 및 자살률의 지역적 편차에 대한 시각적 분석", 한국임상약학회지, 28(4), pp.308~319 (2018), 한국임상약학회[DOI]
  26. 윤제식, "정신건강복지법 비판 : 비자의 입원 요건을 중심으로", 신경정신의학, 57(2), pp.145~156 (2018), 대한신경정신의학회[DOI]
  27. Jamison KR, "Effects of medical interventions on suicidal behavior. Introduction", J Clin Psychiatry, 60(Suppl 2), pp.4~6 (1999)
  28. Gusmão R, "Antidepressant utilization and suicide in europe : an ecological multi-national study", PLoS One, 8, pp.e66455~ (2013)
  29. Rush AJ, "Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps : a STAR*D report", Am J Psychiatry, 163, pp.1905~1917 (2006)
  30. Taylor MA, "Melancholia: The Diagnosis, Pathophysiology, and Treatment of Depressive Disorders" (2006), Cambridge University Press
  31. Fink M, "The role of ECT in suicide prevention", J ECT, 30, pp.5~9 (2014)
  32. Lam RW, "Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. III. Pharmacotherapy", J Affect Disord, 117(Suppl 1), pp.S26~S43 (2009)
  33. Barbui C, "Selective serotonin reuptake inhibitors and risk of suicide : a systematic review of observational studies", CMAJ, 180, pp.291~297 (2009)
  34. Meyer RE, "Suicidality and risk of suicide--definition, drug safety concerns, and a necessary target for drug development : a brief report", J Clin Psychiatry, 71, pp.1040~1046 (2010)
  35. Gibbons RD, "Suicidal thoughts and behavior with antidepressant treatment : reanalysis of the randomized placebo-controlled studies of fluoxetine and venlafaxine", Arch Gen Psychiatry, 69, pp.580~587 (2012)
  36. Spielmans GI, "Inappropriate data and measures lead to questionable conclusions", JAMA Psychiatry, 70, pp.121~122 (2013)
  37. Reinstatler L, "Ketamine as a potential treatment for suicidal ideation : a systematic review of the literature", Drugs R D, 15, pp.37~43 (2015)
  38. Wilkinson ST, "Ketamine : a potential rapid-acting antisuicidal agent", Depress Anxiety, 33, pp.711~717 (2016)
  39. Ionescu DF, "Repeat-dose ketamine augmentation for treatment-resistant depression with chronic suicidal ideation : a randomized, double blind, placebo controlled trial", J Affect Disord, 243, pp.516~524 (2019)
  40. Oji C, "A review of electroconvulsive therapy in suicidality", Ment Health Clin, 5, pp.212~215 (2015)
  41. Payne NA, "Electroconvulsive therapy : Part I. A perspective on the evolution and current practice of ECT", J Psychiatr Pract, 15, pp.346~368 (2009)
  42. Kellner CH, "Handbook of ECT: A Guide to Electroconvulsive Therapy for Practitioners", pp.153~166 (2019), University Press
  43. Weiss A, "The Electroconvulsive Therapy Workbook: Clinical Applications" (2018), Routledge
  44. Kang UG, "Electroconvulsive Therapy: Theory and Practice", pp.33~62 (2019), Seoul National University Press
  45. Petrides G, "Electroconvulsive therapy augmentation in clozapineresistant schizophrenia : a prospective, randomized study", Am J Psychiatry, 172, pp.52~58 (2015)
  46. Grover S, "Treatment Resistance in Psychiatry: Risk Factors, Biology, and Management", pp.109~137 (2019), Springer
  47. "Korea health statistics:cause of death"[URL]
  48. Hermann RC, "Variation in ECT use in the United States", Am J Psychiatry, 152, pp.869~875 (1995)
  49. Maixner DF, "ECT in the United States", Proceedings of the 29th Annual Meeting & ECT Certificate Course (2019)
  50. Leiknes KA, "Contemporary use and practice of electroconvulsive therapy worldwide", Brain Behav, 2, pp.283~344 (2012)
  51. Kellner CH, "The role of ECT in the suicide epidemic", Psychiatr Times, 35, pp.8~ (2018)
  52. "Suicide rates (indicator)"[URL]
  53. Development in Korean Guideline of Electroconvulsive Therapy as a Service for Crisis Intervention in Mental Health, "Chung IW", National Center for Mental Health; Korea Mental Health R&D Project, ~ (2019)
  54. 주성우, "국내 일 대학병원에서 시행된 전기경련요법의현황과 효과 및 안전성", 신경정신의학, 55(3), pp.202~208 (2016), 대한신경정신의학회[DOI]
  55. Youssef NA, "Magnitude of reduction and speed of remission of suicidality for low amplitude seizure therapy(LAP-ST)compared to standard right unilateral electroconvulsive therapy : a pilot double-blinded randomized clinical trial", Brain Sci, 9, pp.99~ (2019)
  56. Samalin L, "Adherence to treatment guidelines in clinical practice for using electroconvulsive therapy in major depressive episode", J Affect Disord, 264, pp.318~323 (2020)
  57. Aksoy-Poyraz C, "Electroconvulsive therapy for bipolar depressive and mixed episode with high suicide risk after epilepsy surgery", Epilepsy Behav, 13, pp.707~709 (2008)
  58. Rapinesi C, "Successful and rapid response to electroconvulsive therapy of a suicidal patient with comorbid bipolar I disorder and histrionic personality disorder", J ECT, 28, pp.57~58 (2012)
  59. Gambill JD, "Suicide after unilateral ECT in a patient previously responsive to bilateral ECT", Psychiatr Q, 55, pp.279~281 (1983)
  60. Tavares AR, "Electroconvulsive therapy(ECT)effective for psychotic recrudescence and suicidality after varenicline adjunctive therapy for smoking cessation in a schizoaffective patient", Braz J Psychiatry, 32, pp.315~316 (2010)
  61. Kobeissi J, "Resolution of severe suicidality with a single electroconvulsive therapy", J ECT, 27, pp.86~88 (2011)
  62. Cormack S, "Index electroconvulsive therapy course to treat severe suicidality and depression in fahr disease", J ECT, 32, pp.72~73 (2016)
  63. Fligelman B, "Resolution of acute suicidality after a single right unilateral electroconvulsive therapy", J ECT, 32, pp.71~72 (2016)
  64. Kellner CH, "A novel strategy for continuation ECT in geriatric depression : phase 2 of the PRIDE study", Am J Psychiatry, 173, pp.1110~1118 (2016)
  65. Tran DV, "Rapid response to electroconvulsive therapy : a case report and literature review", J ECT, 33, pp.e20~e21 (2017)
  66. Kellner CH, "Relief of expressed suicidal intent by ECT : a consortium for research in ECT study", Am J Psychiatry, 162, pp.977~982 (2005)
  67. Kellner CH, "Continuation electroconvulsive therapy vs pharmacotherapy for relapse prevention in major depression : a multisite study from the Consortium for Research in Electroconvulsive Therapy(CORE)", Arch Gen Psychiatry, 63, pp.1337~1344 (2006)
  68. Prudic J, "Electroconvulsive therapy and suicide risk", J Clin Psychiatry, 60(Suppl 2), pp.104~110 (1999)
  69. Rich CL, "Response of energy and suicidal ideation to ECT", J Clin Psychiatry, 47, pp.31~32 (1986)
  70. Patel M, "Should electroconvulsive therapy be an early consideration for suicidal patients", J ECT, 22, pp.113~115 (2006)
  71. Munk-Olsen T, "All-cause mortality among recipients of electroconvulsive therapy : register-based cohort study", Br J Psychiatry, 190, pp.435~439 (2007)
  72. Hunt IM, "Electroconvulsive therapy and suicide among the mentally ill in England : a national clinical survey", Psychiatry Res, 187, pp.145~149 (2011)
  73. Brådvik L, "Long-term treatment and suicidal behavior in severe depression : ECT and antidepressant pharmacotherapy may have different effects on the occurrence and seriousness of suicide attempts", Depress Anxiety, 23, pp.34~41 (2006)
  74. Thomas SG, "Remission of major depression and obsessive-compulsive disorder after a single unilateral ECT", J ECT, 19, pp.50~51 (2003)
  75. The Practice of Electroconvulsive Therapy: Recommendations for Treatment, Training, and Privileging: A task force report of the American Psychiatric Association, "American Psychiatric Association", American Psychiatric Association, ~ (2001)
  76. "Practice guideline for the treatment of patients with major depressive disorder (revision)", Am J Psychiatry, 157, pp.1~45 (2000), American Psychiatric Association
  77. Practice Guidelines for the Treatment of Patients with Schizophrenia, "American Psychiatric Association", American Psychiatric Association, ~ (2010)
  78. VA, "DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide. Version 1.0", The Assessment and Management of Risk for Suicide Working Group, 2013
  79. Guidance on the Use of Electroconvulsive Therapy, "National Institute for Health and Clinical Excellence", National Institute for Health and Clinical Excellence, ~ (2003)
  80. Depression:the treatment and management of depression in adults, "National Collaborating Centre for Mental Health", British Psychological Society, ~ (2010)
  81. Cleare A, "Evidence-based guidelines for treating depressive disorders with antidepressants : a revision of the 2008 British Association for Psychopharmacology guidelines", J Psychopharmacol, 29, pp.459~525 (2015)
  82. Yatham LN, "Canadian Network for Mood and Anxiety Treatments(CANMAT)and International Society for Bipolar Disorders(ISBD)collaborative update of CANMAT guidelines for the management of patients with bipolar disorder : update 2013", Bipolar Disord, 15, pp.1~44 (2013)
  83. Flood RA, "A retrospective examination of psychiatric case records of patients who subsequently committed suicide", Br J Psychiatry, 114, pp.443~450 (1968)
  84. Isometsä ET, "Completed suicide and recent electroconvulsive therapy in Finland", Convuls Ther, 12, pp.152~155 (1996)
  85. Avery D, "Suicide, attempted suicide, and relapse rates in depression", Arch Gen Psychiatry, 35, pp.749~753 (1978)
  86. Tsuang MT, "Can ECT prevent premature death and suicide in"schizoaffective"patients", J Affect Disord, 1, pp.167~171 (1979)
  87. Liang CS, "Superior antisuicidal effects of electroconvulsive therapy in unipolar disorder and bipolar depression", Bipolar Disord, 20, pp.539~546 (2018)
  88. Chang SS, "The role of ECT in suicide management", Taiwanese J Psychiatry, 21, pp.4~15 (2007)
  89. Babigian HM, "Epidemiologic considerations in electroconvulsive therapy", Arch Gen Psychiatry, 41, pp.246~253 (1984)
  90. Black DW, "Does treatment influence mortality in depressives?", Proceedings of The 141st Annual Meeting of the American Psychiatric Association (1988)
  91. Dombrovski AY, "ECT : the preferred treatment for severe depression in late life. ECT : the preferred treatment for severe depression in late life", Int Psychogeriatr, 19, pp.10~14 (2007)
  92. Dubovsky SL, "Mood disorders and the outcome of suicidal thoughts and attempts", Crit Care Clin, 24, pp.857~874 (2008)
  93. Sienaert P, "What we have learned about electroconvulsive therapy and its relevance for the practising psychiatrist", Can J Psychiatry, 56, pp.5~12 (2011)
  94. Foster TJ, "Suicide prevention as a prerequisite for recovery from severe mental illness", Int J Psychiatry Med, 46, pp.15~25 (2013)
  95. 권오준, "응급실로 내원한 자살시도자의 자의 퇴실이 응급실 재방문에 미치는 영향", 대한응급의학회지, 30(5), pp.393~400 (2019), 대한응급의학회
  96. Health Indicators 2011, "Statistics Canada", Canadian Institute for Health Information, ~ (2011)
  97. Chung DT, "Suicide rates after discharge from psychiatric facilities : a systematic review and meta-analysis", JAMA Psychiatry, 74, pp.694~702 (2017)
  98. Mutschler C, "Transition experiences following psychiatric hospitalization : a systematic review of the literature", Community Ment Health J, 55, pp.1255~1274 (2019)
  99. Walter F, "Multiple adverse outcomes following first discharge from inpatient psychiatric care : a national cohort study", Lancet Psychiatry, 6, pp.582~589 (2019)
  100. American Psychiatric Association, "Practice guideline for the assessment and treatment of patients with suicidal behaviors", Am J Psychiatry, 160(11 Suppl), pp.1~60 (2003)
  101. Lin CH, "Factors affecting time to resolution of suicidality for depressed patients receiving electroconvulsive therapy", CNS Spectr, 25, pp.434~435 (2020)
  102. Kuo CJ, "Psychiatric discharge against medical advice is a risk factor for suicide but not for other causes of death", J Clin Psychiatry, 71, pp.808~809 (2010)
  103. Choi M, "Readmission rates of patients discharged against medical advice : a matched cohort study", PLoS One, 6, pp.e24459~ (2011)
  104. 김하늬, "정신건강의학과 입원환자에서 자살행동 관련 요인", 신경정신의학, 58(3), pp.202~208 (2019), 대한신경정신의학회[DOI]
  105. 2018 National Health Insurance Statistical Yearbook, "Health Insurance Review & Assessment Service", Health Insurance Review & Assessment Service;National Health Insurance Service, ~ (2019)
  106. 2018 Medical Aid Statistics, "Health Insurance Review & Assessment Service", Health Insurance Review & Assessment Service; National Health Insurance Service, ~ (2019)
  107. Andrews M, "Effect of two educational interventions on knowledge and attitudes towards electroconvulsive therapy", J ECT, 20, pp.230~236 (2004)
  108. Dowman J, "Electroconvulsive therapy : attitudes and misconceptions", J ECT, 21, pp.84~87 (2005)
  109. Jeong SH, "Electroconvulsive Therapy:Theory and Practice", pp.33~62 (2019), Seoul National University Press

관련 논문AI추천

Trends in Electroconvulsive Therapy Utilization in South Korea: Health Insurance Review Data From 2008 to 2018윤현철, 이문수, 이승훈, Chae En Youn, Changsu Han, Hyun-Ghang Jeong, Suhyuk Chi, Won Seok William Hyung대한신경정신의학회 · PSYCHIATRY INVESTIGATION2024 · 제21권 제7호조현병 환자에서 전기경련요법의 임상적 적용과 효과오상훈대한조현병학회 · 대한조현병학회지2025 · 제28권 제1호노년기 정신장애의 전기경련치료강웅구, 김용식, 김정민, 김희철, 박승현, 이남영, 정인원, 주은정대한생물정신의학회 · 생물정신의학2020 · 제27권 제2호전기경련치료의 최적화를 위한 최근 동향윤탁, 강웅구, 김용식, 정인원대한신경정신의학회 · 신경정신의학2016 · 제55권 제1호국내 일 대학병원에서 시행된 전기경련요법의현황과 효과 및 안전성김창윤, 이중선, 전명욱, 정하은, 주성우, 주연호대한신경정신의학회 · 신경정신의학2016 · 제55권 제3호일 대학병원에서 시행한 전기경련요법의 치료적 효과김양태, 김희철, 정성원, 최영민대한신경정신의학회 · 신경정신의학2015 · 제54권 제3호

이 간행물의 다른 논문 (8건)

전기경련치료에 대한 사회적 낙인과 해소 방안김민아, 권준수, 이준희, 이유상, 김세현pp. 37-41노년기 정신장애의 전기경련치료주은정, 박승현, 김정민, 김용식, 김희철, 정인원, 강웅구, 이남영pp. 42-57항우울제의 사용과 체중조성준, 이웅pp. 58-63Association between Childhood Attention Deficit Hyperactivity Disorder Features and Adulthood Psychological Resilience in Patients with Mood Disorders김의중, 조상현, 방수영, 최재원, 이윤아, 주은정, 이규영pp. 74-83일 직장인의 일주기 유형이 번아웃에 미치는 영향: 우울과 스트레스 반응의 매개 효과 연구김원형, 강상구, 손지성, 맹세리, 이정섭, 이상은, 김혜영, 최서현, 배재남, 이채원pp. 84-93
원문 보기